Israel
· Delayed Price · Currency is ILS · Price in ILA Human Xtensions Statistics
Total Valuation
Human Xtensions has a market cap or net worth of ILS 6.53 million. The enterprise value is 2.50 million.
| Market Cap | 6.53M |
| Enterprise Value | 2.50M |
Important Dates
The last earnings date was Sunday, March 23, 2025.
| Earnings Date | Mar 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Human Xtensions has 26.76 million shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 26.76M |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 38.81% |
| Owned by Institutions (%) | n/a |
| Float | 12.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.80 |
| PB Ratio | 2.24 |
| P/TBV Ratio | 2.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.11 |
| EV / Sales | 3.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.12 |
Financial Position
The company has a current ratio of 1.80
| Current Ratio | 1.80 |
| Quick Ratio | 1.17 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -91.44 |
Financial Efficiency
Return on equity (ROE) is -158.32% and return on invested capital (ROIC) is -104.96%.
| Return on Equity (ROE) | -158.32% |
| Return on Assets (ROA) | -77.49% |
| Return on Invested Capital (ROIC) | -104.96% |
| Return on Capital Employed (ROCE) | -885.20% |
| Revenue Per Employee | 13,300 |
| Profits Per Employee | -459,420 |
| Employee Count | 50 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.44% in the last 52 weeks. The beta is 1.57, so Human Xtensions's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | -51.44% |
| 50-Day Moving Average | 32.06 |
| 200-Day Moving Average | 36.02 |
| Relative Strength Index (RSI) | 31.62 |
| Average Volume (20 Days) | 7,405 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Human Xtensions had revenue of ILS 665,000 and -22.97 million in losses. Loss per share was -0.86.
| Revenue | 665,000 |
| Gross Profit | -2.68M |
| Operating Income | -25.79M |
| Pretax Income | -22.97M |
| Net Income | -22.97M |
| EBITDA | -24.51M |
| EBIT | -25.79M |
| Loss Per Share | -0.86 |
Balance Sheet
The company has 4.03 million in cash and n/a in debt, giving a net cash position of 4.03 million or 0.15 per share.
| Cash & Cash Equivalents | 4.03M |
| Total Debt | n/a |
| Net Cash | 4.03M |
| Net Cash Per Share | 0.15 |
| Equity (Book Value) | 2.91M |
| Book Value Per Share | 0.11 |
| Working Capital | 2.91M |
Cash Flow
In the last 12 months, operating cash flow was -20.84 million and capital expenditures -8,000, giving a free cash flow of -20.85 million.
| Operating Cash Flow | -20.84M |
| Capital Expenditures | -8,000 |
| Free Cash Flow | -20.85M |
| FCF Per Share | -0.78 |
Margins
| Gross Margin | n/a |
| Operating Margin | -3,877.59% |
| Pretax Margin | -3,454.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Human Xtensions does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.11% |
| Shareholder Yield | 0.11% |
| Earnings Yield | -351.86% |
| FCF Yield | -319.40% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |